MedTrace Logo

Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease

NCT01557855 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 342

Last updated 2019-01-31

No results posted yet for this study

Summary

The objective of this study is to collect data on the commercial use of Corus CAD (Age/Sex/Gene Expression score - ASGES) blood test to evaluate the clinical referral patterns of Primary Care Physicians after receipt of their patients' Corus Score, and to better understand patient management patterns for clinicians ordering the test.

Conditions

Interventions

DIAGNOSTIC_TEST

Corus CAD (ASGES)

Age/Sex/Gene Expression Score - ASGES

Sponsors & Collaborators

  • CardioDx

    lead INDUSTRY

Principal Investigators

  • Michael Zapien, MS · CardioDx

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2013-03-31
Completion
2013-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01557855 on ClinicalTrials.gov